References
Tomioka A, Shimizu T, Kagota S, et al. Association between neoadjuvant chemoradiotherapy and intractable serous ascites after pancreaticoduodenectomy for pancreatic cancer. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-09401-w.
Jørgensen MG, Toyserkani NM, Hansen CR, et al. Quantification of chronic lymphedema in a revised mouse model. Ann Plast Surg. 2018;81:594–603.
Haubner F, Ohmann E, Pohl F, Strutz J, Gassner HG. Wound healing after radiation therapy: review of the literature. Radiat Oncol. 2012;7:162.
Verma V, Li J, Lin C. Neoadjuvant therapy for pancreatic cancer: systematic review of postoperative morbidity, mortality, and complications. Am J Clin Oncol. 2016;39:302–13.
Versteijne E, van Eijck CH, Punt CJ, et al. Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial. Trials. 2016;17:127.
Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36:623–50.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tomioka, A., Uchiyama, K. ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer. Ann Surg Oncol 28, 3798–3799 (2021). https://doi.org/10.1245/s10434-020-09413-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-09413-6